UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
Chronimed Inc.
(Name of Issuer)
Common Stock, $0.01 par value
(Title of Class of Securities)
171164106
(CUSIP Number)
Maurice R. Taylor, II
13911 Ridgedale Drive
Minneapolis, MN 55305
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
February 14, 1997
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (However, SEE the
Notes).
SCHEDULE 13D
CUSIP No.
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
SS. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MAURICE R. TAYLOR, II
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE ROW IF A MEMBER OF A GROUP (a)[ ]
(b)[ ]
NOT APPLICABLE
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS
PF
- --------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT [ ]
TO ITEM 2(d) or 2(e)
NOT APPLICABLE
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
UNITED STATES
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
821,957
----------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY
25,825
----------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
821,957
----------------------------------------------
PERSON 10 SHARED DISPOSITIVE POWER
WITH
25,825
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
847,782
- --------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ]
NOT APPLICABLE
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
7.1%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
- --------------------------------------------------------------------------------
STATEMENT FOR SCHEDULE 13D
ITEM 1. SECURITY AND ISSUER
This statement relates to the Common Stock, $0.01 par value, of
Chronimed Inc., whose principal executive offices are located at:
13911 Ridgedale Drive
Minnetonka, MN 55305
ITEM 2. IDENTITY AND BACKGROUND
(a),(b)&(c) The name, address of principal business office and principal
occupation of the person filing is:
Maurice R. Taylor, II
13911 Ridgedale Drive
Minnetonka, MN 55305
Chairman of the Board, President and
Chief Executive Officer of Chronimed Inc.
(d) The undersigned has not, during the last five years, been
convicted in a criminal proceeding (excluding traffic violations
or similar misdemeanors).
(e) The undersigned has not, during the last five years, been a party
to a civil proceeding of a judicial or administrative body of
competent jurisdiction which resulted in such person being
subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to,
federal or state securities laws or finding any violation with
respect to such laws.
(f) The undersigned is a United States Citizen.
ITEMS 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
All shares of common stock of Chronimed Inc. (the "Company") were
acquired with personal funds.
ITEM 4. PURPOSE OF THE TRANSACTION.
The undersigned is a co-founder of the Company and has served as an
officer and director of the Company since 1985, and has held the shares
in connection with the undersigned's involvement as co-founder and an
officer and director of the Company. The undersigned has no current
agreement, arrangement or understanding with the Company or any other
party with respect to any type of transaction enumerated in Item
4(a)-(j) of Schedule 13D.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
(a) The following table sets forth the aggregate number and
percentage of outstanding shares of common stock of Chronimed
Inc. beneficially owned by the undersigned as of the date of
this report:
Number of Shares* Percentage of Outstanding Shares
----------------- --------------------------------
847,782 7.1%
*The above table includes options for the purchase of 141,800
shares of common stock that are exercisable during the next 60
days from the date hereof, but does not include options for the
purchase 262,200 shares of common stock that are not exercisable
within the next 60 days from the date hereof.
(b) The undersigned holds the sole voting power and dispositive
power with respect to 821,957 of the shares listed in Item 5(a)
above and shared voting power and dispositive power with respect
to 25,825 of the shares listed in Item 5(a) above.
(c) The undersigned has not engaged in any transactions in the
Company's common stock during the past sixty days.
(d) No other person (other than the undersigned's spouse with
respect to certain shares) is known to have the right to
receive, or the power to direct the receipt of dividends from,
or to the proceeds from, the sale of such shares of common stock
of the Company held by the undersigned.
(e) Not applicable.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
TO SECURITIES OF THE ISSUER.
As noted in the footnote to the table in Item 5(a) above, certain shares
are subject to issuance upon the exercise of stock options under the
Company's stock option plans.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
None.
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: February 14, 1997
/s/ Maurice R. Taylor, II
---------------------------
Maurice R. Taylor, II
